City of Edinburgh, Scotland, United Kingdom Ingenza is the famous Corporate Investor, which was founded in 2002. The main department of described Corporate Investor is located in the Edinburgh. The company was established in Europe in United Kingdom.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2013. The common things for fund are deals in the range of 100 thousands - 1 million dollars.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Ingenza, startups are often financed by Kelvin Capital, Scottish Enterprise, Lancaster Capital. The meaningful sponsors for the fund in investment in the same round are Kelvin Capital, Scottish Enterprise, Lancaster Capital. In the next rounds fund is usually obtained by Kelvin Capital, Scottish Enterprise, Lancaster Capital.
The fund was created by Ian Fotheringham, Sinil Srivastava.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight ProFactor Pharma. We can highlight the next thriving fund investment areas, such as Medical, Health Care.
Related Funds
| Fund Name | Location |
| Capitan Investment Partners | - |
| Conscious Venture Lab | Baltimore, Maryland, United States |
| Redhouse Capital Management | New York, New York, United States |
| Sapphire Ventures | California, Palo Alto, United States |
| SG Credit Partners | California, Los Angeles, United States |
| Venture Hacks | California, San Francisco, United States |
| Vertex Energy | Houston, Texas, United States |
| View Accelerator | Guadalajara, Jalisco, Mexico |
| YellowRockets.vc | California, San Francisco, United States |
| Yufeng Investment | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ProFactor Pharma | $822K | 31 Aug 2013 | Scotland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ProFactor Pharma | $822K | 31 Aug 2013 | Scotland |
